STIM — Neuronetics Cashflow Statement
0.000.00%
Last trade - 00:00- $294.85m
- $335.63m
- $74.89m
Annual cashflow statement for Neuronetics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -27.5 | -31.2 | -37.2 | -30.2 | -43.7 |
| Depreciation | |||||
| Non-Cash Items | 6.4 | 8.79 | 9.55 | 10.2 | 17.5 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -8.28 | -6.64 | -4.78 | -14.1 | -6.81 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -28.4 | -28 | -30.7 | -32 | -31 |
| Capital Expenditures | -0.73 | -2.35 | -3.27 | -2.37 | -1.47 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -7.49 | 10 | 1.05 | -0.947 |
| Acquisition of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.73 | -9.84 | 6.73 | -1.32 | -2.41 |
| Financing Cash Flow Items | -0.821 | -0.401 | -0.091 | -1.1 | -6.81 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.37 | 83 | 0.207 | 22.7 | -6.81 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -26.8 | 45.2 | -23.8 | -10.7 | -40.2 |